• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

cheasley.d@unimelb.edu.au

Credentials


Position
Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology
ORCID

0000-0002-1170-4690

Dr Dane Cheasley

Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology

31 Scholarly works
4 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Breast cancers arising in high mammographic density tissue harbor tumor-promoting immune profiles
    DOI: 10.1038/s41523-025-00884-y
  • 2026

    Journal article

    Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profile
    DOI: 10.1002/path.70075
  • 2026

    Journal article

    A scalable, multi-resolution consensus clustering approach for prioritizing robust signals from high-throughput screens
    DOI: 10.1093/bib/bbag242
  • 2026

    Journal article

    Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on KRAS/NF1 Mutational Status
    DOI: 10.3390/ijms27041774
  • 2025

    Journal article

    Assessment of candidate high-grade serous ovarian carcinoma predisposition genes through integrated germline and tumour sequencing
    DOI: 10.1038/s41525-024-00447-3
  • 2024

    Research grants (other domestic)

    Preclinical Validation of New Therapeutics for Low-Grade Serous Ovarian Cancer
  • 2020

    Research grants (ARC, NHMRC, MRFF)

    High Throughput Discovery of Synergistic Drug Combinations for Patients With Low-Grade Serous Ovarian Cancer
Dane Cheasley

RECENT SCHOLARLY WORKS

  • 2024

    Journal article

    High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian Carcinoma
    DOI: 10.1038/s41597-024-03869-x
  • 2024

    Journal article

    Molecular Surrogate Subtypes of Ovarian and Peritoneal Low-grade Serous Carcinoma
    DOI: 10.1097/PGP.0000000000001043
  • 2022

    Journal article

    Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
    DOI: 10.1158/1078-0432.CCR-22-1206
  • 2022

    Journal article

    Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
    DOI: 10.1038/s41698-022-00288-2
  • 2021

    Journal article

    Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study
    DOI: 10.1038/s41523-021-00279-9

RECENT PROJECTS

  • 2020

    Research grants (ARC, NHMRC, MRFF)

    High Throughput Discovery of Synergistic Drug Combinations for Patients With Low-Grade Serous Ovarian Cancer
  • 2016

    Research Grant

    Improving Early Detection and Management of Women at Risk of Developing Interval Breast Cancer

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224